Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | ATM | Q13315 | 1/20 | 0.59 |
| ▸ | KIF11 | P52732 | 2/20 | 0.51 |
| ▸ | PPARG | P37231 | 3/20 | 0.48 |
| ▸ | PPARA | Q07869 | 2/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
| ▸ | MPI | P34949 | 1/20 | 0.46 |
| ▸ | PHOSPHO1 | Q8TCT1 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.41 |
| ▸ | GSK3A | P49840 | 1/20 | 0.41 |
| ▸ | GSK3B | P49841 | 1/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30039561 | 1.00 | L3MBTL1 (0.59) | L3MBTL1KDM4EATMKIF11PPARG | |
| SCHEMBL24002585 | 0.94 | KIF11 (0.53) | L3MBTL1KDM4EATMKIF11PPARG | |
| SCHEMBL45634 | 0.91 | L3MBTL1 (0.50) | L3MBTL1KDM4EATMKIF11PPARG | |
| SCHEMBL4728164 | 0.90 | KDM4E (0.48) | L3MBTL1KDM4EATMKIF11PPARG | |
| SCHEMBL13866718 | 0.88 | KDM4E (0.47) | L3MBTL1KDM4EATMKIF11PPARG | |
| SCHEMBL13589236 | 0.88 | L3MBTL1 (0.59) | L3MBTL1KDM4EATMKIF11PPARG | |
| SCHEMBL13589237 | 0.88 | L3MBTL1 (0.59) | L3MBTL1KDM4EATMKIF11PPARG | |
| SCHEMBL30408825 | 0.88 | KDM4E (0.46) | L3MBTL1KDM4EATMKIF11PPARG | |
| SCHEMBL14933491 | 0.86 | TRPV1 (0.51) | L3MBTL1KDM4EATMKIF11PPARG | |
| SCHEMBL25381260 | 0.86 | KIF11 (0.51) | L3MBTL1KDM4EATMKIF11PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210351364-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE | SK MATERIALS JNC CO., LTD. (KR) | 2021-11-11 | — | — | US | disclosed |
| EP-2609080-B1 | N-PHENYL TRISCARBAZOLE | SOLVAY (BE) | 2016-03-30 | — | — | EP | disclosed |
| US-9233922-B2 | Process for producing N-(hetero)arylazoles | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-01-12 | — | — | US | disclosed |
| US-9233922-B2 | Process for producing N-(hetero)arylazoles | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-01-12 | — | — | US | disclosed |
| US-9233922-B2 | Process for producing N-(hetero)arylazoles | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-01-12 | — | — | US | disclosed |
| EP-2736881-B1 | PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES | TAKASAGO PERFUMERY CO LTD (JP) | 2015-10-07 | — | — | EP | disclosed |
| EP-2736881-B1 | PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES | TAKASAGO PERFUMERY CO LTD (JP) | 2015-10-07 | — | — | EP | disclosed |
| US-20140371461-A1 | PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-12-18 | — | — | US | disclosed |
| US-20140371461-A1 | PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-12-18 | — | — | US | disclosed |
| US-20140371461-A1 | PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-12-18 | — | — | US | disclosed |
| EP-2736881-A1 | PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES | Takasago International Corporation (JP) | 2014-06-04 | — | — | EP | disclosed |
| WO-2013032035-A1 | PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-03-07 | — | — | WO | disclosed |
| WO-2013032035-A1 | PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-03-07 | — | — | WO | disclosed |
| EP-2433928-A1 | N-phenyl triscarbazole | Solvay SA (BE) | 2012-03-28 | — | — | EP | disclosed |
| EP-2433928-A1 | N-phenyl triscarbazole | Solvay SA (BE) | 2012-03-28 | — | — | EP | disclosed |
| CN-102031105-A | Bipolar phosphorescence host materials based on tetraphernl silicane substituted carbazoles and organic electroluminescent device | XI AN RUILIAN MODERN ELECTRONIC CHEMICALS CO LTD | 2011-04-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140371461-A1 | PROCESS FOR PRODUCING N-(HETERO)ARYLAZOLES | CYP3A4, HCN4, PPOX | L3MBTL1 4661/4885KDM4E 2867/4885ATM 2252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.